Fortress Biotech, Inc.FBIONASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank93
5Y CAGR+53.4%
Year-over-Year Change
Year-over-year free cash flow growth rate
5Y CAGR
+53.4%/yr
Long-term compound
Percentile
P93
Near historical high
vs 5Y Ago
8.5x
Strong expansion
Streak
3 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 30.17% |
| 2023 | 25.28% |
| 2022 | -37.30% |
| 2021 | -46.28% |
| 2020 | 12.95% |
| 2019 | 3.56% |
| 2018 | -19.07% |
| 2017 | -61.36% |
| 2016 | -74.04% |
| 2015 | -98.11% |